 <h1>Lorabid Pulvules Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>loracarbef</i></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Interactions</li>
<li>Pregnancy</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about loracarbef. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Lorabid Pulvules.</p><p><i>Applies to loracarbef: oral capsule, oral powder for reconstitution</i></p><h3>General</h3><p>Loracarbef (the active ingredient contained in Lorabid Pulvules) is generally well tolerated.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Gastrointestinal side effects have included diarrhea (4.1%), nausea (1.9%), vomiting (1.4%), abdominal pain (1.4%), and anorexia.  The incidence of side effects increases with higher doses.  Pseudomembranous colitis has been reported in patients treated with beta-lactam antibiotics.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Nervous system side effects have included headache (2.9%), somnolence, insomnia, and dizziness.  Some beta-lactam antibiotics have been associated with seizures in renally impaired patients.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Hypersensitivity reactions have included rash (1.2%), urticaria, pruritus, and erythema multiforme.  Anaphylaxis, serum-sickness-like reactions, and Stevens-Johnson syndrome have been reported rarely.  Beta-lactam antibiotics have been associated with toxic epidermal necrolysis,<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Respiratory side effects have included rhinitis (1.6%).<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Hematologic side effects have included transient thrombocytopenia, leukopenia, and eosinophilia.  Beta-lactam antibiotics as a class have been associated with agranulocytosis, aplastic anemia, hemolytic anemia, hemorrhage, positive direct Coombs' test, pancytopenia, neutropenia, and prolonged prothrombin time.<sup>[Ref]</sup></p><h3>Renal</h3><p>Renal side effects have included transient elevations in serum creatinine and BUN.  Some beta-lactam antibiotics have been associated with toxic nephropathy.<sup>[Ref]</sup></p><h3>Hepatic</h3><p>A 73-year-old man developed itching and jaundice, pale stools, and right upper quadrant pain two weeks after completion of a four week course of loracarbef (the active ingredient contained in Lorabid Pulvules) for pneumonia.  Bilirubin, AST, ALT, alkaline phosphatase levels were elevated.  Liver biopsy showed widening of portal areas, pericellular fibrosis, and irregular fibrous bands in the parenchyma.  Swollen hepatocytes and cholestasis in the cytoplasma and canaliculi were observed.  Lab values returned to normal after 10 weeks.<sup>[Ref]</sup></p><p>Hepatic side effects have included transient elevations in AST (SGOT), ALT (SGPT), and alkaline phosphatase.  Hepatic dysfunction including cholestasis with or without jaundice has been rarely reported.  Some beta-lactam antibiotics have been associated with LDH elevations.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Cardiovascular side effects have included vasodilatation.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Genitourinary side effects have included vaginitis (1.3%) and vaginal moniliasis (1.1%).<sup>[Ref]</sup></p><p id="ref_1">1. Therasse DG "The safety profile of loracarbef: clinical trials in respiratory, skin, and urinary tract infections." Am J Med 92 (1992): s20-5</p><p id="ref_2">2. Brogden RN, McTavish D "Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy." Drugs 45 (1993): 716-36</p><p id="ref_3">3. "Product Information. Lorabid (loracarbef)." Lilly, Eli and Company, Indianapolis, IN. </p><p id="ref_4">4. Bjornsson E, Olsson R "Acute liver injury due to loracarbef." J Hepatol 26 (1997): 739-40</p><h2>More about Lorabid Pulvules (loracarbef)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Drug class: second generation cephalosporins</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Bacterial Infection</li>
<li>Bladder Infection</li>
<li>Bronchitis</li>
<li>Impetigo</li>
<li data-more-config-id="list-data-resources-conditions">... +7 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>